A rare BRAF BRAF BRAF T599dup mutation conferring sensitivity to BRAF BRAF inhibitor in a patient with metastatic melanoma

Marchand A.; Tallet A.; Collin C.; Cormier B.; Venel Y.; Miquelestorena‐Standley E.; Machet L.

首页> 外文期刊>British Journal of Dermatology >A rare BRAF BRAF BRAF T599dup mutation conferring sensitivity to BRAF BRAF inhibitor in a patient with metastatic melanoma

【24h】

A rare BRAF BRAF BRAF T599dup mutation conferring sensitivity to BRAF BRAF inhibitor in a patient with metastatic melanoma

机译：一个漂亮的稀有稀有T599DUP突变赋予患者敏感性敏感性较好的抑制剂在转移性黑色素瘤中

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Dermatology》 |2018年第2期|共2页
作者
Marchand A.; Tallet A.; Collin C.; Cormier B.; Venel Y.; Miquelestorena‐Standley E.; Machet L.;
展开▼
作者单位

Department of DermatologyCHRU ToursTours France;

Platform of Somatic Tumor Molecular GeneticsCHRU ToursTours France;

Platform of Somatic Tumor Molecular GeneticsCHRU ToursTours France;

PathologyCHRU ToursTours France;

Nuclear MedicineCHRU ToursTours France;

PathologyCHRU ToursTours France;

Department of DermatologyCHRU ToursTours France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. A rare BRAF BRAF BRAF T599dup mutation conferring sensitivity to BRAF BRAF inhibitor in a patient with metastatic melanoma [J] . Marchand A., Tallet A., Collin C., British Journal of Dermatology . 2018,第2期

机译：一个漂亮的稀有稀有T599DUP突变赋予患者敏感性敏感性较好的抑制剂在转移性黑色素瘤中
2. A rare pitfall in the molecular interpretation of BRAF BRAF V600E status in melanoma in the setting of BRAF BRAF V600E‐mutated chronic lymphocytic leukemia/small lymphocytic lymphoma [J] . Johnstone Kate J., Strutton Geoffrey M. Journal of cutaneous pathology . 2019,第6期

机译：在BRAF BRAF V600E-突变慢性淋巴细胞白血病/小淋巴细胞淋巴瘤中，黑色素瘤中BRAF BRAF V600E状态分子解释的罕见缺陷
3. Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma [J] . HalaitH., DemartinK., ShahS., Diagnostic molecular pathology : . 2012,第1期

机译：基于实时PCR的BRAF基因V600突变测定的分析性能，用作新型BRAF抑制剂维拉非尼在转移性黑色素瘤中的辅助诊断测试
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. NRAS and BRAF mutations in primary cutaneous melanoma: A comparison of mutation rates between radial and vertical growth phases in individual tumors. [D] . Greene, Victoria R. 2007

机译：原发性皮肤黑素瘤中的NRAS和BRAF突变：单个肿瘤在径向和垂直生长期之间的突变率比较。
6. Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma [O] . Jessie Villanueva, Jeffrey R. Infante, Clemens Krepler, -1

机译：同时发生MEK2突变和BRAF扩增赋予黑色素瘤对BRAF和MEK抑制剂的耐药性
7. BRAF V600E protein expression and outcome from BRAF inhibitor treatment in BRAF V600E metastatic melanoma [O] . Wilmott, J. S, Menzies, A. M, Long, G. V, 2013

机译：BRAF V600E转移性黑色素瘤中BRAF V600E的蛋白表达和BRAF抑制剂治疗的结果

A rare BRAF BRAF BRAF T599dup mutation conferring sensitivity to BRAF BRAF inhibitor in a patient with metastatic melanoma

著录项

相似文献

相关主题

期刊订阅